These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21535871)

  • 1. Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis.
    Vempati P; Popel AS; Mac Gabhann F
    BMC Syst Biol; 2011 May; 5():59. PubMed ID: 21535871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.
    Vempati P; Popel AS; Mac Gabhann F
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):1-19. PubMed ID: 24332926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model.
    Vempati P; Mac Gabhann F; Popel AS
    PLoS One; 2010 Jul; 5(7):e11860. PubMed ID: 20686621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy.
    Mac Gabhann F; Ji JW; Popel AS
    PLoS Comput Biol; 2006 Sep; 2(9):e127. PubMed ID: 17002494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial distribution of VEGF isoforms and chemotactic signals in the vicinity of a tumor.
    Small AR; Neagu A; Amyot F; Sackett D; Chernomordik V; Gandjbakhche A
    J Theor Biol; 2008 Jun; 252(4):593-607. PubMed ID: 18395755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.
    Clegg LE; Mac Gabhann F
    PLoS Comput Biol; 2017 Mar; 13(3):e1005445. PubMed ID: 28319199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study.
    Krilleke D; Ng YS; Shima DT
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1201-6. PubMed ID: 19909247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action.
    Ferrara N
    Mol Biol Cell; 2010 Mar; 21(5):687-90. PubMed ID: 20185770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF
    Chu LH; Ganta VC; Choi MH; Chen G; Finley SD; Annex BH; Popel AS
    Sci Rep; 2016 Nov; 6():37030. PubMed ID: 27853189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor isoforms in the Japanese quail embryo.
    Finkelstein EB; Poole TJ
    Growth Factors; 2003 Mar; 21(1):41-9. PubMed ID: 12795335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle.
    Mac Gabhann F; Ji JW; Popel AS
    J Appl Physiol (1985); 2007 Feb; 102(2):722-34. PubMed ID: 17038488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches.
    Mac Gabhann F; Popel AS
    PLoS Comput Biol; 2006 Dec; 2(12):e180. PubMed ID: 17196035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.
    Lee S; Jilani SM; Nikolova GV; Carpizo D; Iruela-Arispe ML
    J Cell Biol; 2005 May; 169(4):681-91. PubMed ID: 15911882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation.
    Halder JB; Zhao X; Soker S; Paria BC; Klagsbrun M; Das SK; Dey SK
    Genesis; 2000 Mar; 26(3):213-24. PubMed ID: 10705382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model.
    Clegg LW; Mac Gabhann F
    PLoS Comput Biol; 2015 Jun; 11(6):e1004158. PubMed ID: 26067165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.
    Peach CJ; Mignone VW; Arruda MA; Alcobia DC; Hill SJ; Kilpatrick LE; Woolard J
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model.
    Lee TY; Folkman J; Javaherian K
    PLoS One; 2010 Apr; 5(4):e9945. PubMed ID: 20376344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.
    Ebrahem Q; Chaurasia SS; Vasanji A; Qi JH; Klenotic PA; Cutler A; Asosingh K; Erzurum S; Anand-Apte B
    Am J Pathol; 2010 Jan; 176(1):496-503. PubMed ID: 19948826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases.
    Poltorak Z; Cohen T; Neufeld G
    Herz; 2000 Mar; 25(2):126-9. PubMed ID: 10829252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.